What is optimal endocrine therapy in a young, premenopausal women with ER/PR positive oligometastic breast cancer successfully treated with curative intent neoadjuvant chemo followed by surgery+RT to skeletal oligomet?

Would you include a CDK4/6 inhibitor knowing the patient doesn't meet criteria of monarchE trial but still is Stage IV?

Answer from: Medical Oncologist at Academic Institution

These cases are always important to understand what discussions were had up front with the patient and all members of the team regarding goals of care. It seems the patient was treated with "curative" intent; however, the likelihood that she has actually been cured of her disease is extremely low an...

Comments

Medical Oncologist at NYU Winthrop Hospital
Data from MONALEESA-3 trial.

Please select the option that best describes you:

What is optimal endocrine therapy in a young, premenopausal women with ER/PR positive oligometastic breast cancer successfully treated with curative intent neoadjuvant chemo followed by surgery+RT to skeletal oligomet?

Related Questions